Revenue
attach_money236M USD
YoY +47.5%
AKBAAkebia Therapeutics, Inc.$ --
Akebia Therapeutics, Inc.
AKBA
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart23M USD
YoY +146.6%
Net Income
verified-5M USD
YoY +92.3%
EPS
pie_chart-0.02USD
YoY +93.7%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress53.5%On Track
Revenue Progress53.5M
Revenue Forecast231.4M
Net Income Progress-9.1M
Net Income Forecast-16.9M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.